Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by ...
Business Wire1 个月
Arcturus Therapeutics Announces Appointment of Moncef Slaoui, Ph.D., as Chair Designate
and Synflorix, to prevent pneumococcal disease. In 2016, Dr. Slaoui was recognized as one of Fortune's 50 Greatest World Leaders for his work in under-researched diseases common in the developing ...
pharmaphorum12 年
GSK submits new application for Synflorix to EMA
GlaxoSmithKline has submitted a regulatory application to the European Medicines Agency (EMA) seeking approval of an additional indication for Synflorix in the European Union (EU). This ...